CLEVER HANDELN

Richten Sie Börsennews.de als Startseite ein

Hier klicken

OMEROS Aktie

VERISK ANALYTICS INC. REGISTERED SHS CL.A DL -,001

ISIN: US92345Y1064

 | 

WKN: A0YA2M

 | 

Symbol: VA7A

 | 

Land:


37,28 EUR -0,4912%

Die besten Rohstoffaktien der Welt

Zu Ihrem Onlinebroker

kaufen verkaufen
Deutsche Bank DAB bank AG OnVista Bank ViTrade 1822direkt flatex S Broker comdirect ING DiBa Sino Cortal Consors maxblue TARGOBANK alle vergleichen
Deutsche Bank DAB bank AG OnVista Bank ViTrade 1822direkt flatex S Broker comdirect ING DiBa Sino Cortal Consors maxblue TARGOBANK alle vergleichen

OMEROS Aktienkurs

: 09:01 ( 15 Min. verzögert)
37,28 €
Letzter Kurs
 -0,49%
Veränderung
 37,46 €
Vortag
 37,28 €
Eröffnungskurs

Alle News aus dem Web zur OMEROS Aktie

  • 23.05.

    Did You Buy These Stocks?

    Omeros Corp. (OMER) is a biopharmaceutical company focused on developing products for inflammation, bleeding and disorders of the central nervous system. OMER was trading around $3.94 when we alerted…

  • 19.05.

    CRM, FL, VELT, BWS, WGO Had Unusual Volume

    Omeros Corp. (NASDAQ:OMER) had a 87.3% volume spike trading 536026 shares. OMER's 30-day average volume is 67942. Shares closed at $9.52 +3.93%. Omeros Corporation is a clinical-stage biopharmaceutical Company committed to discovering, developing and ...

  • 15.05.

    Table of Unusual NASDAQ Stock Moves From RealTick

    ... US EXCHANGE: NASDAQ TIME PERIOD: 9:30 - 12:20 LAST CHANGE %CHANGE RANK COMPANY NAME TICKER PRICE ON DAY ON DAY 1 OMEROS CORP OMER 9.73 0.23 2.42 2 PERION NETWORK LTD PERI 4.70 0.42 ...

  • 14.05.

    Semi-Annual Changes to the NASDAQ Biotechnology Index

    ... Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) , Jazz Pharmaceuticals plc (NASDAQ:JAZZ) , Omeros Corporation (NASDAQ:OMER) , Orexigen Therapeutics, Inc. (NASDAQ:OREX) , Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) , Raptor Pharmaceutical Corp.

  • 10.05.

    Omeros Corporation Reports First Quarter 2012 Financial Results

    SEATTLE, May 10, 2012 /PRNewswire via COMTEX/ -- Omeros Corporation (NASDAQ:OMER) , a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of...